Want to put some lead in your pencil? Try nitinol instead. The wonder metal—a nickel-titanium alloy with heat-activated shape memory—has proved essential for Wisconsin and Illinois researchers building what British tabloids are calling a “bionic penis.” Chuckles aside, the proposed implant has enough potential advantages over existing erectile dysfunction treatment implants that Boston Scientific officials […]
University of Wisconsin spinal surgeon Dr. Thomas Zdeblick is in the hot seat over a running tab with med-tech titan Medtronic Inc. (NYSE:MDT) that’s topped $25 million since 2003.
During that time, Zdeblick, chairman of the university’s orthopedics and rehabilitation department, co-authored several favorable research papers about Medtronic’s spine products, according to the Milwaukee Journal-Sentinel.
MASSDEVICE ON CALL — U.S. med-tech makers are likely to invest in buyback programs and acquisitions and to pursue dividends to maintain shareholder value, according to Moody’s Investors Service.
As pricing pressures continue to weigh on the industry and demand remains soft, medical device makers are likely to look elsewhere to spur growth and keep stakeholders happy.
Sector revenue growth may also remain soft thanks to a weak global economy, MarketWatch reported.